TY  - GEN
AU  - Mayer,K
AU  - Schulz,S
AU  - Bernlochner,I
AU  - Morath,T
AU  - Braun,S
AU  - Hausleiter,J
AU  - Massberg,S
AU  - Schunkert,H
AU  - Laugwitz,K-L
AU  - Kastrati,A
AU  - Sibbing,D
TI  - A comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity. Results of the ISAR-HPR registry
SN  - 2567-689X
PY  - 2015///1015
KW  - Aged
KW  - Aged, 80 and over
KW  - Blood Platelets
KW  - drug effects
KW  - Case-Control Studies
KW  - Clopidogrel
KW  - Coronary Thrombosis
KW  - etiology
KW  - Drug Resistance
KW  - Drug Substitution
KW  - Female
KW  - Germany
KW  - Hemorrhage
KW  - chemically induced
KW  - Humans
KW  - Logistic Models
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Percutaneous Coronary Intervention
KW  - adverse effects
KW  - Piperazines
KW  - Platelet Aggregation
KW  - Platelet Aggregation Inhibitors
KW  - Platelet Function Tests
KW  - Prasugrel Hydrochloride
KW  - Precision Medicine
KW  - Predictive Value of Tests
KW  - Proportional Hazards Models
KW  - Prospective Studies
KW  - Purinergic P2Y Receptor Antagonists
KW  - Receptors, Purinergic P2Y12
KW  - blood
KW  - Registries
KW  - Risk Factors
KW  - Thiophenes
KW  - Ticlopidine
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1160/TH13-10-0874
ER  -